FDA Inspection 556264 — Shenzhen Hepalink Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shenzhen Hepalink Pharmaceutical Co., Ltd. on November 26, 2008 in Shenzhen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 26, 2008
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shenzhen (China)